30 words
Handelsbanken lowers target price for Nobia to SEK 10.70 (14), reiterates hold - BN
www.marketscreener.com Construction Supplies & Fixtures Handelsbanken lowers target price for Nobia to SEK 10.70 (14), reiterates hold - BN
Install
Latest in Analyst Ratings & Targets
69 words
Ahold Delhaize N.V.: RBC is Neutral
RBC analyst Manjari Dhar maintains his Neutral opinion on the stock. The target price is unchanged at EUR 37. Food Retail & Distribution Ahold Delhaize N.V.: RBC is Neutral Published on 11/04/2026 at 05:02 am EST Latest news about Ahold Delhaize N.V. Chart Ahold Delhaize N.V. Income…
41 words
Deutsche Bank Raises Price Target on Match Group to $50 From $45, Keeps Buy Rating
www.marketscreener.com Deutsche Bank Raises Price Target on Match Group to $50 From $45, Keeps Buy Rating Published on 11/03/2026 at 09:06 am EST
26 words
Article - RBC
RBC Enhances Cash Back Mastercard Portfolio with Unlimited Cash Back and On-Demand Redemptions RBC Royal Bank of Canada Website, © 1995- Legal | Accessibility | Privacy & Security | Advertising & Cookies
27 words
Deutsche Bank Adjusts Ethos Technologies Price Target to $40 From $30, Maintains Buy Rating
... Life & Health Insurance Deutsche Bank Adjusts Ethos Technologies Price Target to $40 From $30, Maintains Buy Rating Published on 08/04/2026 at 07:49 am EDT
98 words
Deutsche Bank Upgrades Healthcare Realty Trust to Buy From Hold, Adjusts PT to $23 From $18
Healthcare Realty Trust (HR) has an average rating of overweight and mean price target of $21.58, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research... Oops, something went wrong Deutsche Bank Upgrades Healthcare Realty Trust to…
49 words
Deutsche Bank Upgrades Healthcare Realty Trust to Buy From Hold, Price Target is $23
Healthcare Realty Trust has an average rating of overweight and mean price target of $21.08, according to analysts polled by FactSet.... Healthcare Realty Trust Incorporated Deutsche Bank Upgrades Healthcare Realty Trust to Buy From Hold, Price Target is $23 Published on 10/20/2026 at…
263 words
Hikma Pharmaceuticals PLC (LON:HIK) Stock Has Consensus Price Target of GBX 2,085.83
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have received an average rating of “Buy” from the six research firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with…
283 words
SK hynix (NASDAQ:SKHY) Stock Gets Price Target Reduction from Cantor Fitzgerald
Posted by Danessa Lincoln on Oct 26th, 2026 SK hynix (NASDAQ:SKHY – Get Free Report) had its price target lowered by equities research analysts at Cantor Fitzgerald from $300.00 to $250.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has…
153 words
Discovery Mining price target raised to C$16 from C$15 at CIBC
CIBC raised the firm’s price target on Discovery Mining (DSVSF) to C$16 from C$15 and keeps an Outperformer rating on the shares. The firm adjus... Discovery Mining price target raised to C$16 from C$15 at CIBC CIBC raised the firm’s…
Analyst Ratings & Targets
Upgrades, downgrades, and price target moves across sectors.
- 18 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.